Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ampio Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ampio Pharmaceuticals Inc market cap is $3,100.00.
What is the 52-week high for Ampio Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ampio Pharmaceuticals Inc 52 week high is $0.1347 as of September 13, 2025.
What is the 52-week low for Ampio Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ampio Pharmaceuticals Inc 52 week low is $0.0001 as of September 13, 2025.
What is Ampio Pharmaceuticals Inc stock price today?
Ampio Pharmaceuticals Inc stock price today is $0.0027.
What was Ampio Pharmaceuticals Inc stock price yesterday?
Ampio Pharmaceuticals Inc stock price yesterday was $0.0027.
What is the 50-day moving average of Ampio Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ampio Pharmaceuticals Inc 50-day moving average is $0.0047.